Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

(2011) P. Pacher et al.   PROGRESS IN LIPID RESEARCH

The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

(2010) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats

(2010) Andrew J. Hill et al.   EPILEPSIA

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury

(2010) Partha Mukhopadhyay et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

(2010) Mohanraj Rajesh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

(2009) Partha Mukhopadhyay et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice

(2009) Gernot Riedel et al.   BRITISH JOURNAL OF PHARMACOLOGY

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

(2009) Partha Mukhopadhyay et al.   CARDIOVASCULAR RESEARCH

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy

(2009) Nicole Defer et al.   FASEB JOURNAL

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

(2009) Sasidhar Murikinati et al.   FASEB JOURNAL

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy

(2009) Mohanraj Rajesh et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

(2009) Fabrizio Montecucco et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury

(2009) Ming Zhang et al.   MICROVASCULAR RESEARCH

The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum

(2008) Y-L Ma et al.   BRITISH JOURNAL OF PHARMACOLOGY

Oxidative Inactivation of Key Mitochondrial Proteins Leads to Dysfunction and Injury in Hepatic Ischemia Reperfusion

(2008) Kwan–Hoon Moon et al.   GASTROENTEROLOGY

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death

(2008) H. Pan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

(2008) Mauro Maccarrone et al.   NATURE NEUROSCIENCE

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning

(2007) P Pacher et al.   BRITISH JOURNAL OF PHARMACOLOGY

The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo

(2007) R G Pertwee et al.   BRITISH JOURNAL OF PHARMACOLOGY